RIO DE JANEIRO, BRAZIL - According to the Ministry of Health, Brazil will have approximately 140 million doses of a vaccine against the coronavirus for the first half of next year. There will be 100 million doses from the agreement with Astrazeneca Pharmaceutical, which holds the Oxford University immunizer license, and another 42.5 million from the COVAX Facility initiative of the World Health Organization.
The production of 100 to 165 million doses of the Oxford vaccine by Fiocruz is also scheduled for the second semester, totaling at least 240 million doses of the vaccine against the novel coronavirus for 2021 . . .